Back
Interaction of ergotamine with liver Cytochrome P450 3A in rats
Ali S. Moubarak, Hehai Wang, Zelpha B. Johnson, Charles F. Rosenkrans
Agric. Sci. Vol.3 No.6, October 16, 2012  DOI: 10.4236/as.2012.36096
       (PDF  165K)     HTML     
Determination of Synthetic Impurities and Metabolic Products of F-ADAM, a Positron Emission Tomography Imaging Agent for Serotonin Transporter (SERT) Using HPLC-Tandem Mass Spectrometry
Wei-Hsi Chen, Chyng-Yann Shiue
Pharmacol. Pharm. Vol.11 No.10, October 31, 2020  DOI: 10.4236/pp.2020.1110023
       (PDF  3238K)     HTML      XML
Liver Function and Structure in Rats Treated Simultaneously with Cadmium and Mercury
Samir Haouem, Issam Chargui, Mohamed Fadhel Najjar, Badreddine Sriha, Abdelhamid El Hani
Open J. Pathol. Vol.3 No.1, January 28, 2013  DOI: 10.4236/ojpathology.2013.31005
       (PDF  1637K)     HTML      XML
Evaluation of the effect of compound aqueous solubility in cytochrome P450 inhibition assays
José Pérez, Caridad Díaz, Irene G. Salado, Daniel I. Pérez, Fernando Peláez, Olga Genilloud, Francisca Vicente
Adv. Biosci. Biotechnol. Vol.4 No.5, May 30, 2013  DOI: 10.4236/abb.2013.45083
       (PDF  821K)     HTML     
Characterization of in vitro and in vivo metabolism of AG-024322, a novel cyclin-dependent kinase (CDK)
Wei-Zhu Zhong, Bojan Lalovic, Jenny Zhan
Health Vol.1 No.4, December 29, 2009  DOI: 10.4236/health.2009.14041
       (PDF  550K)     HTML     
 
 
Top